Thrombospondin-1-Based Antiangiogenic Therapy.

Sims, Jennifer N; Lawler, Jack

Sims, Jennifer N; Lawler, Jack.

Affiliation

Sims JN; Department of Pathology, Beth Israel Deaconess Medical Center , Harvard Medical School, Boston, Massachusetts.
Lawler J; Department of Pathology, Beth Israel Deaconess Medical Center , Harvard Medical School, Boston, Massachusetts.

J Ocul Pharmacol Ther ; 31(7): 366-70, 2015 Sep.

Article in En | MEDLINE | ID: mdl-26352160

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Eye Diseases/drug therapy; Eye/blood supply; Eye/drug effects; Thrombospondin 1/therapeutic use; Angiogenesis Inhibitors/adverse effects; Angiogenesis Inhibitors/pharmacology; Blindness/drug therapy; Blindness/etiology; Eye/pathology; Eye Diseases/pathology; Humans; Neovascularization, Pathologic/drug therapy; Thrombospondin 1/adverse effects; Thrombospondin 1/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombospondin 1 / Angiogenesis Inhibitors / Eye / Eye Diseases Type of study: Etiology_studies Limits: Humans Language: En Journal: J Ocul Pharmacol Ther Journal subject: FARMACOLOGIA / OFTALMOLOGIA / TERAPEUTICA Year: 2015 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google